metabolic · guide

Retatrutide

Triple-receptor GLP-1 / GIP / glucagon.

What it is

Next-generation incretin agonist. Hits three metabolic receptors for the most aggressive fat-loss profile available.

Who runs it

Experienced, plateaued on tirzepatide, monitoring closely.

Typical protocol

0.5mg subq weekly, slow titration. Bloodwork required.

What to track

Notable shifts within 4–6 weeks for most.

Where it fits in a stack

Retatrutide pairs naturally with the peptides we curate around the same goal. See our stacks page for combinations we'd actually run.

Ready to run it?

From $420/mo. Fulfilled by Peptides ATX. Pre-loads into Sundial after checkout.

For research use only. This is not medical advice. Talk to a clinician.